Patent · US Active

Therapeutic preparation of very high purity FVIIa and method for obtaining same

US7531513B2 · kind B2 · utility

1Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 8, 2007
Grant dateMay 12, 2009
Priority date
Expiry dateFeb 8, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P7/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The therapeutic preparation of FVIIa having a purity of at least 1000 IU/mg of protein is characterized in that said preparation is free of proteins of non-human origin. In the method for obtaining FVII, purification starts from FrII+III, FrIII or equivalent of Cohn fractioning and comprises precipitation with PEG, chromatography and its subsequent activation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.